0000818479false00008184792026-06-022026-06-02

WASHINGTON, D.C. 20549

Date of Report (Date of earliest event reported)

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of Principal Executive Offices)

(Zip Code)

(844) 848-0137

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on June 2, 2026. The following matters were voted upon at the Annual Meeting, with the results indicated:

1.Election of twelve directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified.

			Director			For			Against			Abstain			Broker Non-Votes
1a.			Michael J. Barber			167,115,711			642,651			82,953			14,762,922
1b.			James D. Forbes			167,030,832			726,831			83,652			14,762,922
1c.			Brian T. Gladden			167,131,075			633,358			76,882			14,762,922
1d.			Betsy D. Holden			144,275,619			23,407,281			158,415			14,762,922
1e.			Clyde R. Hosein			166,571,426			1,166,383			103,506			14,762,922
1f.			Gregory T. Lucier			164,966,222			2,723,724			151,369			14,762,922
1g.			Jonathan J. Mazelsky			164,501,688			3,177,506			162,121			14,762,922
1h.			Brian P. McKeon			167,101,344			657,813			82,158			14,762,922
1i.			Daniel T. Scavilla			167,087,998			674,884			78,433			14,762,922
1j.			Leslie F. Varon			166,054,818			1,611,470			175,027			14,762,922
1k.			Janet S. Vergis			165,269,825			2,490,769			80,721			14,762,922
1l.			Donald J. Zurbay			116,568,821			51,059,271			213,223			14,762,922

2.Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2026.

For			Against			Abstain			Broker Non-Votes
182,033,381			465,064			105,792			—

3.Approval, by non-binding advisory vote, of the Company’s executive compensation for 2025.

For			Against			Abstain			Broker Non-Votes
158,496,058			9,090,084			255,173			14,762,922

4.Approval of Amendment No. 2 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 15,000,000 shares.

For			Against			Abstain			Broker Non-Votes
139,933,388			27,713,777			194,150			14,762,922

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DENTSPLY SIRONA Inc.

Date: June 4, 2026